SCHEMBL22632088

SCHEMBL22632088

CNCCc1cc(=O)oc2cc(NCCN(C)C)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC18A1 P54219 1/20 0.54
▸ SLC18A2 Q05940 1/20 0.54
▸ RAD52 P43351 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CYP2D6 P10635 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA4 P22748 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ HSD17B3 P37058 3/20 0.42
▸ AR P10275 1/20 0.42
▸ ALB P02768 4/20 0.41
▸ GAA P10253 1/20 0.41
▸ ERAP1 Q9NZ08 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623266 0.87 RAD52 (0.48) SLC18A1SLC18A2RAD52ALDH1A1KDM4E
SCHEMBL24623582 0.87 RAD52 (0.48) SLC18A1SLC18A2RAD52ALDH1A1KDM4E
SCHEMBL22632306 0.86 MTNR1B (0.53) SLC18A1SLC18A2RAD52ALDH1A1KDM4E
SCHEMBL24623269 0.84 RAD52 (0.45) SLC18A1SLC18A2RAD52ALDH1A1KDM4E
SCHEMBL22632229 0.79 SLC18A1 (0.50) SLC18A1SLC18A2ALDH1A1KDM4EPOLB
SCHEMBL22632227 0.76 SLC18A1 (0.59) SLC18A1SLC18A2ALDH1A1KDM4EHPGD
SCHEMBL22632085 0.74 ALDH1A1 (0.69) SLC18A1SLC18A2ALDH1A1KDM4EPOLB
SCHEMBL22632087 0.74 CYP2D6 (0.76) ALDH1A1KDM4EHPGDHSD17B10CYP2D6
SCHEMBL15082514 0.70 HSD17B3 (0.72) ALDH1A1KDM4EHPGDCASP1CASP7
SCHEMBL29360977 0.70 SLC18A1 (1.00) SLC18A1SLC18A2ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback